October 24, 2025

Elinzanetant Approved for Menopausal Hot Flashes by FDA

Bayer’s dual neurokinin 1 and 3 receptor antagonist elinzanetant (Lynkuet) reduced the frequency and severity of menopausal vasomotor symptoms in phase 3 OASIS trials, providing a once daily, nonhormonal treatment option for moderate to severe hot flashes.

Conexiant

October 23, 2025

Is the Estradiol Ring Losing Strength Early?

Patients reported return of vasomotor symptoms before the 3-month mark in real-world use. 

Conexiant

September 30, 2025

Long COVID &  Periods: What's the Link?

Researchers examine menstrual changes and immune patterns in patients with long COVID.

Conexiant

September 26, 2025

Age 80 and Beyond: The Screening Debate

How mammography after age 80 affects breast cancer stage at diagnosis and survival.

Conexiant

November 14, 2024

Can Botox Ease Chronic Pelvic Pain?

A recent study assessed the efficacy of Botulinum Toxin A injections in conjunction with pelvic floor muscle therapy for women with chronic pelvic pain, revealing interesting insights into its effectiveness compared to a placebo.

Conexiant

April 28, 2025

More Menopause Symptoms, Greater Cognitive Risk

Study demonstrates dose-dependent relationship: each additional menopausal symptom associated with poorer cognitive function and increased behavioral changes in later life.

Conexiant

August 20, 2025

USO Tied to Lower HGSC Risk, Study Shows

Researchers assess whether unilateral salpingo-oophorectomy before age 50 lowers cancer risk without raising cardiovascular or bone complications.

Conexiant

February 25, 2025

Early Perimenopause Symptoms and Health Care-Seeking in U.S. Women

Researchers highlighted significant perimenopause symptoms and health care-seeking behaviors among women as young as 30.

Conexiant

January 31, 2025

Fresh vs. Frozen Embryo Transfer: IVF Outcomes

Fresh embryo transfer may improve live birth rates over frozen transfer in women with low ovarian reserve undergoing in vitro fertilization.

Conexiant